Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients
β Scribed by Robert C. Smith; Carol A. Tamminga; John W. Crayton; Haroutune Dekirmenjian; John M. Davis
- Book ID
- 104771577
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 464 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
β¦ Synopsis
The relationship of plasma prolactin to plasma or red blood cell butaperazine levels was investigated in chronic schizophrenic patients treated with clinical doses of butaperazine, both after a single acute dose of the drug and during regular, twice daily butaperazine administration. Although there was a significant curvilinear relationship between peak plasma butaperazine levels after an acute single oral dose of butaperazine and the maximum prolactin response that we measured, steady-state levels of plasma or red cell butaperazine and plasma prolactin were not related. We conclude that plasma prolactin cannot be used as a substitute for or even as a rough indicator of butaperazine blood levels in chronic schizophrenic patients being treated with clinical doses of butaperazine.
π SIMILAR VOLUMES
Serum and cerebrospinal fluid (CSF) concentrations of fluphenazine (FPZ) were measured during nine weeks of FPZ medication in 28 patients with acute symptoms of schizophrenia. A significant correlation was found between the serum and CSF FPZ values (r = 0.70, p < 0-001) throughout the entire study.